aibioPSNL Personalis, Inc.
Personalis (PSNL) news
Personalis, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker PSNL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Personalis news
We have not published a story on Personalis yet. When there is news, it will appear here.
Personalis annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $69.6 million | $84.6 million |
| Research and development | $50.3 million | $48.9 million |
| Net income (loss) | -$81.3 million | -$81.3 million |
| Cash from operations | -$74.9 million | -$45.1 million |
| Cash and equivalents | $124.2 million | $91.4 million |
| Short-term investments | $115.7 million | $93.6 million |
Questions about Personalis
What is the ticker symbol of Personalis?
Personalis, Inc. trades under the ticker PSNL on NASDAQ.
Where is Personalis listed?
Personalis, Inc. is listed on NASDAQ.
Which country or territory is Personalis listed under?
Our directory records Personalis, Inc. under United States.
Does aibio.space cover Personalis?
aibio.space lists Personalis, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
What was Personalis's revenue last year?
$69.6 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Personalis profitable?
Personalis, Inc. reported a net loss of $81.3 million for the fiscal year ended Dec 31, 2025, and used $74.9 million of cash in operations, per its annual report to the SEC.
How much does Personalis spend on research and development?
$50.3 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Personalis have?
$212.7 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Investor discussion: Personalis
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
Stock chart
Listing details
- Company
- Personalis, Inc.
- Ticker
- PSNL
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction